Xcopri (cenobamate)

cenobamate · SK Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xcopri (cenobamate), covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures [Phase 3]

See pricing